FDA Grants Soligenix Orphan Drug Designation To Active Ingredient In MarVax For Prevention And Post-Exposure Prophylaxis Against Marburg Marburgvirus Infection
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.